At the Medicap Pharmacy® stores, we are dedicated to providing products and services to care for your family’s wellness. One of those services is health news you can trust. Use the filters to focus on the information that is important to you, then bookmark this page to make it a regular stop anytime you’re online.
BRCA Mutations: Who Should Get Tested?
BRCA1 and BRCA2 gene mutations increase breast cancer risk. So how do you know if you have these gene mutations?
Several New Medications Approved
As a new year begins, we celebrate the beginning of something new and exciting. This year, that includes several new medication approvals from the US Food and Drug Administration (FDA).
Detecting Breast Cancer Early
Performing regular breast self-exams can make all the difference in women's health.
More Exercise, Less Disease
Many past studies have shown that physical activity provides health benefits, but exactly how much physical activity provides the most benefit?
Cancer Screening: It Could Be Hard to Get the Facts
Most people would agree that cancer screening is a good thing. After all, you're either preventing cancer or catching it early. Unfortunately, the majority of cancer screening guidelines may be lacking in important patient information.
Standard Medication for HER-2 Breast Cancer Remained Top Rx
The approval of a new medication represents new options for patients. But the new option isn't always the best option. When it comes to treating HER-2 positive breast cancer, the standard medication still appears to beat the newer option.
Call for Genetic Screening to Become New Norm
Gene mutations associated with higher rates of breast and ovarian cancer may pose a serious risk to Ashkenazi Jewish (AJ) women, even those without a family history of cancer. This prompted a call for more genetic cancer screening.
Men With Breast Cancer Treated Differently
While breast cancer is one of the most common cancers in women, it’s one of the least common in men. Both sexes have similar survival rates. However, researchers have discovered major differences in treatment approaches.
FDA Expands Use of Breast Cancer Rx
For the first time in its history, the US Food and Drug Administration has approved a medication for the pre-surgical (neoadjuvant) treatment of early-stage (I, II) breast cancer.
Accelerated FDA Review For HER2-Positive Drug
HER2-positive breast cancer is one of the most aggressive forms of the disease. A new treatment option may soon be available to help battle this vicious cancer.